P&G to co-promote Somaxon's Silenor in the US
This article was originally published in Scrip
Executive Summary
Somaxon Pharmaceuticals and Procter & Gamble Pharmaceuticals are to co-promote Somaxon's insomnia drug Silenor (low-dose doxepin) in the US.